Preventing congenital rubella infection in the European Region of WHO: 2010 target.
The World Health Organisation (WHO) Regional Office for Europe has recently published a strategic plan and surveillance guidelines for measles and congenital rubella infection. The strategy prioritizes measles control activities but encourages the introduction of rubella vaccine when measles vaccine coverage has reached >90 %; although, many western European countries with suboptimal measles vaccine coverage are already using the combined measles, mumps and rubella (MMR) vaccine. Women in these countries may have an especially high risk of having an infant with congenital rubella syndrome. WHO is seeking to improve the surveillance for rubella and congenital rubella syndrome as a means to obtain better information on the burden of these diseases and engage policy decision makers in the need to support the WHO European Region's strategies for rubella.
Spika
J S
JS
World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Hanon
F X
FX
Wassilak
S
S
Pebody
R
R
Emiroglu
N
N
D005060:Europe; D006293:Health Promotion; D006801:Humans; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine; D014944:World Health Organization
D012411:Rubella Vaccine